PIK3CA mutation status in Japanese lung cancer patients

Lung Cancer

Volumn 54, Issue 2, 2006, Pages 209-215

  Kawano, Osamu ^a   Sasaki, Hidefumi ^a   Endo, Katsuhiko ^a   Suzuki, Eriko ^a   Haneda, Hiroshi ^a   Yukiue, Haruhiro ^a   Kobayashi, Yoshihiro ^a   Yano, Motoki ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Genotyping; LightCycler; Lung cancer; Mutations; PIK3CA

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER SURGERY; CONTROLLED STUDY; ENZYME ACTIVE SITE; EXON; FEMALE; FUNCTIONAL ASSESSMENT; GENE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; JAPAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PHOSPHATIDYLINOSTITOL 3 KINASE CATALYTIC SUBUNIT GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SOMATIC MUTATION; UNIVERSITY HOSPITAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; EXONS; FEMALE; GENES, ERBB-1; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; SMOKING; SURVIVAL;

EID: 33751084640     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.07.006     Document Type: Article

References (33)

1. Karakas B., Bachman K.E., and Park B.H. Mutation of the PIK3CA oncogene in human cancers. Br J Cancer 94 (2006) 455-459
2. Samuels Y., Wang Z., Bardelli A., Silliman N., Ptak J., Szabo S., et al. High frequency of mutations of the PIK3CA gene in human cancers. Science (2004) 304-554
3. Bachman K.E., Argani P., Samuels Y., Sillima N., Ptak J., Szabo S., et al. The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther 3 (2004) 772-775
4. Lee J.W., Soung Y.H., Kim S.Y., Lee H.W., Park W.S., Nam S.W., et al. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 24 (2005) 1477-1480
5. Campbell I.G., Russell S.E., Choong D.Y., Montgomery K.G., Ciavarella M.L., Hooi C.S.F., et al. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 64 (2004) 7678-7681
6. Broderick D.K., Di C., Parrett T.J., Samuels Y.R., Cummins J.M., McLendon R.E., et al. Mutations of PIK3CA gene in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas. Cancer Res 64 (2004) 5048-5050
7. Wang Y., Helland A., Holm R., Kristensen G.B., and Borresen-Dale A.L. PIK3CA mutation in advanced ovarian carcinomas. Hum Mutant 25 (2005) 322
8. Kang S., Bader A.G., and Vogt P.K. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci USA 102 (2005) 802-807
9. Wittwer C.T., Herrmann M.G., Moss A.A., and Rasmussen R.P. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 22 (1997) 130-138
10. Wittwer C.T., Reed G.B., and Ririe K.M. Rapid cycle amplification. In: Mullis K.B., Ferre F., and Gibbs R.A. (Eds). The polymerase chain reaction (1994), Birkhauser, Boston Br J 174-81
11. Pals G., Pindolia K., and Worsham M.J. A rapid and sensitive approach to mutation detection using real-time polymerase chain reaction and melting curve analyses, using BRCA1 as an example. Mol Diagn 4 (1999) 241-246
12. Wittwer T., Ririe M., Andrew V., David A., Gungry A., and Bali J. The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 22 (1997) 176-181
13. Japan Lung Cancer Society, General Rule for Clinical and Pathological Record of Lung Cancer, 5th ed. The Japan Lung Cancer Society 1999;5:1-177.
14. Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304 (2004) 1497-1500
15. Endo K., Konishi A., Sasaki H., Takada M., Tanaka H., Okumura M., et al. Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay. Lung Cancer 50 (2005) 375-384
16. Sasaki H., Endo K., Konishi A., Takada M., Kawahara M., Iuchi K., et al. EGFR mutation status in Japanese lung cancer patients: genotyping analysis using LighyCycler. Clin Cancer Res 11 (2005) 2924-2929
17. Sasaki H., Shimizu S., Endo K., Takada M., Kawahara M., Tanaka H., et al. EGFR and erbB2 mutation status in Japanese lung cancer patients. Int J Cancer 118 (2006) 180-184
18. Whyte D.B., and Holbeck S.L. Correlation of PIK3CA mutations with gene expression and drug sensitivity in NCI-60 cell lines. Biochem Biophys Res Commun 340 (2006) 469-475
19. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Branniga B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. New Eng J Med 53 (2004) 1192-1202
20. Pao W., Miller V., Zakowski M., Doherty J., Politi K., Sarkari I., et al. EGF receptor gene mutations are common in lung cancer from "never smokers" and are associated with sensitivity of tumors to gefitinib and elrotinib. Proc Natl Acad Sci 101 (2004) 13306-13311
21. Li V.S., Wong C.W., Chan T.L., Chan A.S., Zhao W., Chu K.M., et al. Mutations of PIK3CA in gastric adenocarcinoma. BMC Cancer 5 (2005) 29
22. Qiu W., Schonleben F., Li X., Ho D.J., Close L.G., Manolidis S., et al. PIK3CA mutations in head and neck squamous cell carcinoma. Clin Cancer Res 12 (2006) 1441-1446
23. Phillips W.A., Russell S.E., Ciavarell M.L., Choong D.Y., Montgomery K.G., Smith K., et al. Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus. Int J Cancer 118 (2006) 2644-2646
24. Pals G., Young C., Mao H.S., and Worsham M.J. Detection of a single base substitution in a single cell using the LightCycler. J Biochem Biophys Methods 47 (2001) 121-129
25. Heid C.A., Stevens J., and William P.M. Real time quantitative PCR. Genome Res 6 (1996) 986-994
26. Inoue T., Kanai F., Hikiba Y., Obata T., Tanaka Y., Imamura J., et al. Functional analysis of PIK3CA gene mutations in human colorectal cancer. Cancer Res 65 (2005) 4562-4567
27. Kang S., Bader A.G., and Vogt P.K. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci USA 102 (2005) 802-807
28. Samuel Y., Dia Jr. L.A., and Schmidt-Kittler. Mutant PIK3CA promote cell growth and invasion of human cancer cells. Cancer Cell 7 (2005) 561-573
29. Bader A.G., Kang S., and Vogt P.K. Cancer-specific mutations in PIK3CA are oncogenic in vivo. Proc Natl Acad Sci USA 103 (2006) 1475-1479
30. Sugita M., Tanaka N., Davidson S., Sekiya S., Varella-Garcia M., West J., et al. Molecular definition of a small amplification domain within 3q26 in tumors of cervix ovary, and lung. Cancer Genet Cytogenet 117 (2000) 9-18
31. Chujo M., Noguchi M., Miura T., Arinaga M., Uchida Y., and Tagawa Y. Comparative genomic hybridization analysis detected frequent overrepresentation of chromosome 3q in squamous cell carcinoma of the lung. Lung Cancer 38 (2002) 23-29
32. Racz A., Brass N., Heckel D., Pahl S., Remberger K., and Meese E. Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma. Eur J Cancer 35 (1999) 641-646
33. Oda K., Stokoe D., Taketani Y., and McCormick F. High frequency of coexistent mutations of PIK3CA an PTEN gene in endometrial carcinoma. Cancer Res 65 (2005) 10669-10673